CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to REGN

Phase 3

Development Phase

4

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Q3 '27
REGNPhase 2

Placebo Phase 2 Est. Readout

Dupilumab
Q3 2027~QSTALE
CT.gov
00%
Dec '26
REGNPhase 2

Dupilumab Phase 2 Est. Readout

Dupilumab
Dec 2026~
CT.gov
00%
Nov '26
REGNPhase 2

Dupilumab Phase 2 Est. Readout

Dupilumab
Nov 2026~
CT.gov
00%
Oct '26
REGNPhase 3

Dupilumab Phase 3 Est. Readout

Dupilumab
Oct 2026~
CT.gov
00%
Competitive Landscape

0 competitors in Atopic Dermatitis (AD)

View Full Landscape
Drug Information

Target Indication

Atopic Dermatitis (AD)

Clinical Trial

NCT01979016

Last updated: 1/2/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.